Applied UV, Inc., Announces Full Exercise of Over-Allotment Option as of July 29, 2021

Applied UV, Inc. (NASDAQ:AUVI), an infection prevention technology company that applies the power of narrow-range ultra violet light (“UVC”) to destroy pathogens safely, thoroughly, and automatically, announced late last month the underwriters of its 10.5% Series A Cumulative Perpetual Preferred Stock exercised in full their over-allotment option to purchase an additional 72,000 shares of Series A Preferred Stock from Applied UV at a price to the public of $25.00 per share for gross proceeds of $1.8 million, prior to deducting underwriting discounts and commissions. After giving effect to the exercise of the over-allotment option, a total of 552,000 shares were…